2,4-dinitrobenzenesulfonic acid has been researched along with Disease Models, Animal in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.22) | 18.7374 |
| 1990's | 3 (6.67) | 18.2507 |
| 2000's | 16 (35.56) | 29.6817 |
| 2010's | 24 (53.33) | 24.3611 |
| 2020's | 1 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| von Andrian, UH | 1 |
| Jeong, S; Jung, Y; Kim, D; Kim, W; Yang, Y; Yoo, JW | 1 |
| Banzato, S; Barbieri, V; Brun, P; Caputi, V; Castagliuolo, I; De Caro, R; Giron, MC; Grillo, AR; Martines, D; Palù, G; Pizzuti, D; Porzionato, A; Qesari, M; Rosato, A; Spagnol, L; Sturniolo, GC; Zaninotto, G; Zoppellaro, C | 1 |
| Antonioli, L; Blandizzi, C; Caputi, V; Colucci, R; Fornai, M; Giron, MC; Orso, G; Pellegrini, C; Sacco, D; Scarpignato, C; Tuccori, M | 1 |
| Cho, CH; Wong, VK; Yu, L | 1 |
| Antonioli, L; Awwad, O; Bin, A; Blandizzi, C; Castagliuolo, I; Colucci, R; Fornai, M; Gaion, RM; Ghisu, N; Giron, MC; Tuccori, M; Zoppellaro, C | 1 |
| Antonioli, L; Awwad, O; Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M | 1 |
| Cosenza, V; D'Argenio, G; Di Marzo, V; Scaglione, G; Sorrentini, I; Valenti, M | 1 |
| Horiuchi, Y; Okuno, T; Yamanishi, K | 1 |
| Cook, GA; Giraud, AS; Thim, L; Tran, CP; Yeomans, ND | 1 |
| Natsuaki, M; Sagami, S; Yamashita, N | 1 |
| Chain, F; Cherbuy, C; Escribano-Vazquez, U; Langella, P; Martin, R; Thomas, M; Verstraeten, S | 1 |
| Joshi, N; Mishra, N; Singh, A; Thakur, V | 1 |
| Algieri, F; Gálvez, J; Garrido-Mesa, J; Gómez-Caravaca, AM; Monteleone, G; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Segura-Carretero, A; Talhaoui, N; Utrilla, MP; Vezza, T | 1 |
| Amini-Khoei, H; Amiri, S; Dehpour, AR; Haj-Mirzaian, A; Hosseini, MJ; Momeny, M; Rahimi-Balaei, M | 1 |
| Baj, A; Bistoletti, M; Caon, I; Crema, F; Filpa, V; Frigo, G; Giaroni, C; Giron, MC; Grimaldi, A; Karousou, E; Moretto, P; Moro, E; Passi, A; Vigetti, D; Viola, M | 1 |
| Badr, AM; Khairy, H; Marie, MS; Saleh, H | 1 |
| Jirků Pomajbíková, K; Jirků, M; Levá, J; Morien, E; Parfrey, LW; Sobotková, K | 1 |
| Cordaro, M; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Gugliandolo, E; Impellizzeri, D; Perretti, M | 1 |
| Choi, EJ; Debnath, T; Han, KI; Iwasa, M; Kim, EK; Kim, WJ; Kobayashi, K; Kwak, YS; Lee, HJ; Tang, Y; Yoon, JH | 1 |
| Azevedo, VA; Bermúdez-Humarán, LG; Breyner, NM; Chain, F; Chatel, JM; de Azevedo, M; de Carvalho, RD; Fernandes, G; Langella, P; Michel, ML; Myioshi, A; Rochat, T; Sokol, H; Vilas Boas, PB | 1 |
| Bridle, BW; Ghia, JE; Hedlund, PB; Khan, WI; Kim, JJ; Manocha, MM; Rengasamy, P; Shajib, MS; Syed, SN; Wan, Y; Wang, H | 1 |
| Collins, M; Denburg, JA; Denou, E; Ghia, JE; Khan, WI; Kim, JJ; Shajib, MS; Sunjic, I; Wang, H | 1 |
| Battista, G; Borrelli, F; Capasso, R; Coppola, D; Di Marzo, V; Izzo, AA; Orlando, P; Pagano, E; Petrosino, S; Romano, B | 1 |
| Ahmad, A; Bruschetta, G; Campolo, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Navarra, M | 1 |
| Agbor, TA; Buret, AG; Ferraz, JG; Flannigan, KL; Motta, JP; Wallace, JL; Wang, R | 1 |
| Bercik, P; Bermúdez-Humarán, LG; Chain, F; Jury, J; Langella, P; Lu, J; Martín, R; Miquel, S; Natividad, JM; Sokol, H; Theodorou, V; Verdu, EF | 1 |
| Costantino, G; Crisafulli, C; Cuzzocrea, S; Fries, W; Longo, G; Mazzon, E; Muja, C | 1 |
| Caminiti, R; Cuzzocrea, S; Dal Toso, R; Di Paola, R; Esposito, E; Mazzon, E; Pressi, G; Riccardi, L | 1 |
| McKay, DM; Melon, A; Phan, V; Wang, A | 1 |
| Bailón, E; Celada, A; Comalada, M; Cueto-Sola, M; Gálvez, J; Garrido-Mesa, N; Nieto, A; Utrilla, P; Xaus, J; Zarzuelo, A | 1 |
| Acet, A; Kaya, E; Parlakpinar, H; Tasdemir, S; Vardi, N | 1 |
| Caputi, AP; Cuzzocrea, S; Mazzon, E; Puzzolo, D | 1 |
| Brigidi, P; Campieri, M; Eliakim, R; Gionchetti, P; Karmeli, F; Morgenstern, S; Rachmilewitz, D; Shibolet, O; Swennen, E | 1 |
| Assi, K; Gómez-Muñoz, A; Jacobson, K; Owen, D; Parhar, K; Salh, B; Templeman, V | 1 |
| Heck, AJ; Houtman, R; Humphery-Smith, I; Kool, M; Krijgsveld, J; Nijkamp, FP; Redegeld, FA; Romijn, EP | 1 |
| Bendtzen, K; Buschard, K; Di Marco, R; Mangano, K; Musumeci, R; Nicoletti, F; Papaccio, G; Quattrocchi, C; Speciale, AM | 1 |
| Boyer, L; Buchan, AM; Ghoreishi, M; Jacobson, K; Jevon, G; Templeman, V; Vallance, BA | 1 |
| Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Li, JH; Malleo, G; Massuda, E; Mazzon, E; Min, WK; Muià, C; Wang, ZQ; Xu, W; Zhang, J | 1 |
| Bhol, KC; Schechter, PJ | 1 |
| Crisafulli, C; Cuzzocrea, S; Fries, W; Mazzon, E; Muja, C | 1 |
| Appleyard, CB; Beck, PL; Carter, L; Le, T; Wallace, JL | 1 |
| Hogaboam, CM; Huang, JQ; Hunt, RH; Padol, I | 1 |
| Ceri, H; Howard, SR; Lang, MD; Nickel, JC; Olson, ME | 1 |
| Brazowski, E; Dotan, I; Halpern, Z; Hershkoviz, R; Karmeli, F; Peled, Y; Rachmilewitz, D | 1 |
45 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and Disease Models, Animal
| Article | Year |
|---|---|
NK cell memory: discovery of a mystery.
Topics: Allergy and Immunology; Animals; Benzenesulfonates; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; DNA-Binding Proteins; Herpesviridae Infections; History, 21st Century; Humans; Immunologic Memory; Killer Cells, Natural; Liver; Mice; Mice, Knockout; Mice, SCID; Models, Animal; Muromegalovirus; Skin; Urinary Bladder | 2021 |
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azo Compounds; Benzenesulfonates; Colitis; Colon; Disease Models, Animal; Male; Mesalamine; Metoclopramide; Prodrugs; Rats; Rats, Sprague-Dawley | 2019 |
Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.
Topics: Animals; Benzenesulfonates; Colitis; Dextran Sulfate; Disease Models, Animal; Enteric Nervous System; Glial Cell Line-Derived Neurotrophic Factor; Inflammation; Male; Mice; Mice, Knockout; Neuroglia; Neurons; Signal Transduction; Toll-Like Receptor 2 | 2013 |
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
Topics: Adenosine Triphosphate; Animals; Benzenesulfonates; Colitis; Disease Models, Animal; Guanidines; Male; Muscle, Smooth; Neurons; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7 | 2014 |
Protective effect of polysaccharides from Angelica sinensis on ulcerative colitis in rats.
Topics: Angelica sinensis; Animals; Apoptosis; Benzenesulfonates; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Neutrophil Infiltration; Oxidative Stress; Plant Extracts; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2008 |
Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation.
Topics: Adenosine; Adenosine Deaminase; Animals; Benzenesulfonates; Carbachol; Colitis; Colon; Disease Models, Animal; Electric Stimulation; Fluorescent Antibody Technique; Male; Myenteric Plexus; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis.
Topics: 5'-Nucleotidase; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Benzenesulfonates; Colitis; Colon; Disease Models, Animal; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Xanthines | 2011 |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
Topics: Adult; Aged; Amidohydrolases; Animals; Arachidonic Acids; Benzenesulfonates; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Evaluation, Preclinical; Endocannabinoids; Female; Glycerides; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Mice; Mice, Inbred C57BL; Middle Aged; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Serotonin; Specific Pathogen-Free Organisms; Trinitrobenzenesulfonic Acid | 2006 |
Mild reduction of generalized rash in guinea pigs experimentally infected with varicella zoster virus or herpes simplex virus type 1.
Topics: Animals; Benzenesulfonates; Dermatitis, Atopic; Dermatitis, Exfoliative; Disease Models, Animal; Female; Guinea Pigs; Herpes Simplex; Herpes Zoster; Irritants; L-Lactate Dehydrogenase; Skin Diseases, Viral; Urticaria | 1995 |
Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.
Topics: Administration, Rectal; Animals; Benzenesulfonates; Chronic Disease; Colitis; Disease Models, Animal; Ethanol; Growth Substances; Humans; Male; Mucins; Muscle Proteins; Neuropeptides; Peptides; Peroxidase; Rats; Rats, Wistar; Recombinant Proteins; Trefoil Factor-2; Trefoil Factor-3 | 1999 |
Flare-up reaction on murine contact hypersensitivity. I. Description of an experimental model: rechallenge system.
Topics: Animals; Benzenesulfonates; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Female; Injections, Intravenous; Lymphocyte Activation; Mice; Mice, Inbred BALB C | 1989 |
The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model.
Topics: Animals; Benzenesulfonates; Chronic Disease; Colitis; Colon; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Gene Expression Regulation; Germ-Free Life; Host Microbial Interactions; Humans; Interleukin-10; Intestinal Mucosa; Male; Mice; Severity of Illness Index; Symbiosis | 2019 |
Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis:
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzenesulfonates; Caco-2 Cells; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Female; Humans; Lactobacillus acidophilus; Male; Mesalamine; Particle Size; Polymethacrylic Acids; Probiotics; Rats; Rats, Wistar | 2019 |
Immunomodulatory properties of Olea europaea leaf extract in intestinal inflammation.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Caco-2 Cells; Cell Line, Tumor; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Intestinal Mucosa; Intestines; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred C57BL; Olea; Phytotherapy; Plant Extracts; Plant Leaves; RAW 264.7 Cells | 2017 |
Anxiety- and Depressive-Like Behaviors are Associated with Altered Hippocampal Energy and Inflammatory Status in a Mouse Model of Crohn's Disease.
Topics: Animals; Anxiety; Behavior, Animal; Benzenesulfonates; Colitis; Crohn Disease; Depression; Disease Models, Animal; Encephalitis; Hippocampus; Inflammation; Male; Mitochondria; Nitric Oxide | 2017 |
Changes in hyaluronan deposition in the rat myenteric plexus after experimentally-induced colitis.
Topics: Animals; Benzenesulfonates; Cells, Cultured; Colitis; Colon; Disease Models, Animal; Gastrointestinal Motility; Gene Expression Regulation; Humans; Hyaluronan Synthases; Hyaluronic Acid; Male; Mitochondrial Proteins; Myenteric Plexus; Neurons; Protein Transport; Rats; Rats, Sprague-Dawley | 2017 |
Therapeutic efficacy of osthole against dinitrobenzene sulphonic acid induced-colitis in rats.
Topics: Animals; Antioxidants; Benzenesulfonates; Colitis; Coumarins; Cytokines; Disease Models, Animal; Male; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
The benign helminth Hymenolepis diminuta ameliorates chemically induced colitis in a rat model system.
Topics: Animals; Benzenesulfonates; Colitis; Colon; Disease Models, Animal; Female; Hymenolepis diminuta; Inflammation; Interleukin-10; Interleukin-13; Interleukin-4; Life Cycle Stages; Male; Rats; Rats, Wistar; Th2 Cells | 2018 |
Formyl peptide receptor 1 signalling promotes experimental colitis in mice.
Topics: Animals; Benzenesulfonates; Colitis; Colon; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Formyl Peptide; Signal Transduction | 2019 |
Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model.
Topics: Animals; Benzenesulfonates; Colon; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Enterococcus faecalis; Female; Inflammatory Bowel Diseases; Mice | 2019 |
Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.
Topics: Animals; Antimicrobial Cationic Peptides; Benzenesulfonates; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Lactococcus lactis; Mice; Mice, Inbred C57BL; Pancreatitis-Associated Proteins; Peptides | 2019 |
Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation.
Topics: Animals; Benzenesulfonates; Colitis; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Inflammation; Intestinal Mucosa; Intestines; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Receptors, Serotonin | 2013 |
Interleukin 13 and serotonin: linking the immune and endocrine systems in murine models of intestinal inflammation.
Topics: Animals; Benzenesulfonates; Colitis; Dextran Sulfate; Disease Models, Animal; Endocrine System; Interleukin-13; Macrophages, Peritoneal; Mice; Mice, Knockout; Serotonin | 2013 |
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Benzenesulfonates; Capsaicin; Colitis; Colon; Disease Models, Animal; Endocannabinoids; Ethanolamines; Intestinal Absorption; Male; Mice, Inbred ICR; Oleic Acids; Palmitic Acids; Peroxidase; PPAR alpha; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; RNA, Messenger; TRPV Cation Channels | 2015 |
The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzenesulfonates; Beverages; Citrus; Colitis; Colon; Disease Models, Animal; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Mice; Neutrophil Infiltration; NF-kappa B; P-Selectin; Peroxidase; Plant Extracts; Poly Adenosine Diphosphate Ribose; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation | 2015 |
Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α.
Topics: Allyl Compounds; Animals; Benzenesulfonates; Colitis; Cystathionine gamma-Lyase; Disease Models, Animal; Disulfides; Gene Expression; HT29 Cells; Humans; Hydrogen Sulfide; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mustard Compounds; Phenylpropionates; Protein Stability; Rats; Rats, Wistar; Wound Healing | 2015 |
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.
Topics: Animals; Benzenesulfonates; Clostridiales; Colon; Cytokines; Disease Models, Animal; Enteritis; Mice; Permeability; Serotonin | 2015 |
Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Apoptosis; Benzenesulfonates; Blotting, Western; Colitis; Disease Models, Animal; Enterocytes; Etanercept; Fas Ligand Protein; Immunoglobulin G; Immunohistochemistry; In Situ Nick-End Labeling; Infliximab; Male; Mice; Mice, Knockout; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha | 2008 |
Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Topics: Ajuga; Animals; Benzenesulfonates; Caffeic Acids; Cell Line; Chromatography, High Pressure Liquid; Colitis; Colon; Disease Models, Animal; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nitric Oxide Synthase Type II; P-Selectin; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Trisaccharides; Tumor Necrosis Factor-alpha | 2009 |
Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Benzenesulfonates; Colitis; Collagen; Cytokines; Dexamethasone; Disease Models, Animal; Eosinophils; Histocytochemistry; Hymenolepiasis; Hymenolepis diminuta; Male; Mice; Mice, Inbred BALB C; Spleen | 2010 |
DNFB-DNS hapten-induced colitis in mice should not be considered a model of inflammatory bowel disease.
Topics: Animals; Benzenesulfonates; Colitis; Cytokines; Dinitrofluorobenzene; Disease Models, Animal; Drug Hypersensitivity; Haptens; Humans; Immunoenzyme Techniques; Inflammation; Intestinal Mucosa; Lymphocytes; Male; Mast Cells; Mice; Mice, Inbred BALB C | 2011 |
Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Caspase 3; CD4-Positive T-Lymphocytes; Colitis; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Erythropoietin; Flow Cytometry; Goblet Cells; Male; Melatonin; Rats; Rats, Wistar | 2013 |
Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis.
Topics: Alanine Transaminase; Animals; Benzenesulfonates; Bilirubin; Colitis; Colon; Cytokines; Disease Models, Animal; Hepatocytes; Interleukin-10; Lanthanum; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Tight Junctions | 2002 |
Variable response to probiotics in two models of experimental colitis in rats.
Topics: Alkylating Agents; Animals; Benzenesulfonates; Bifidobacterium; Colitis; Disease Models, Animal; Intestinal Mucosa; Iodoacetamide; Lactobacillus; Male; Probiotics; Rats; Rats, Sprague-Dawley; Streptococcus | 2002 |
Curcumin attenuates DNB-induced murine colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzenesulfonates; Biomarkers; Colitis; Curcumin; Disease Models, Animal; Humans; Intestinal Mucosa; MAP Kinase Signaling System; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases | 2003 |
Lung proteome alterations in a mouse model for nonallergic asthma.
Topics: Actins; Alcohol Oxidoreductases; Animals; Annexin A6; Asthma; Benzenesulfonates; Data Interpretation, Statistical; Dinitrofluorobenzene; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Gas Chromatography-Mass Spectrometry; Gelsolin; Glutathione Transferase; Heat-Shock Proteins; Hypersensitivity, Delayed; Isoelectric Focusing; Lung; Mice; Mice, Inbred BALB C; Microfilament Proteins; Nerve Tissue Proteins; Proteins; Proteome; Proteomics; Serum Albumin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Talin; Vinculin | 2003 |
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Benzenesulfonates; Colitis, Ulcerative; Disease Models, Animal; Fusidic Acid; Histocytochemistry; Interferon-gamma; Male; Rats; Rats, Inbred Lew; Tumor Necrosis Factor-alpha; Weight Loss | 2003 |
Myenteric plexus injury and apoptosis in experimental colitis.
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Apoptosis; Benzenesulfonates; Caspase 3; Caspases; Cell Count; Colitis; Disease Models, Animal; ELAV Proteins; ELAV-Like Protein 3; Female; Immunohistochemistry; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Myenteric Plexus; Nerve Tissue Proteins; Neurons; Peroxidase; RNA-Binding Proteins; Statistics, Nonparametric; Time Factors; Ubiquitin Thiolesterase | 2005 |
Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.
Topics: Animals; Benzenesulfonates; Cell Death; Colitis; Disease Models, Animal; Fas Ligand Protein; Glycoside Hydrolases; Inflammatory Bowel Diseases; Interleukin-1beta; Mice; Peroxidase; Tumor Necrosis Factor-alpha | 2007 |
Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis.
Topics: Animals; Benzenesulfonates; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Drug Administration Routes; Follow-Up Studies; Haptens; Immunohistochemistry; Intestinal Mucosa; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metal Nanoparticles; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Silver; Treatment Outcome | 2007 |
Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Benzenesulfonates; Claudins; Colitis; Disease Models, Animal; Enterocytes; Etanercept; Gastrointestinal Agents; Ileum; Immunoglobulin G; Infliximab; Male; Membrane Proteins; Mice; Mice, Knockout; Occludin; Phosphoproteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tight Junctions; Time Factors; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2008 |
Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid.
Topics: Animals; Benzenesulfonates; Colitis; Dinitrochlorobenzene; Disease Models, Animal; Haptens; Male; Neutrophils; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1995 |
Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis.
Topics: Animals; Benzenesulfonates; Colitis, Ulcerative; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Inflammatory Bowel Diseases; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Sulfonamides; Trinitrobenzenesulfonic Acid | 2000 |
Rat model of experimentally induced abacterial prostatitis.
Topics: Animals; Benzenesulfonates; Central Nervous System Depressants; Disease Models, Animal; Ethanol; Inflammation; Male; Mucous Membrane; Prostatitis; Rats; Rats, Sprague-Dawley | 2000 |
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Benzenesulfonates; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Heparin; Iodoacetamide; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2001 |